- Email: [email protected]
A Look at International Meeting
a look at inter,national meetings ore than 1,200 people from 40 countries attended the 22nd General Assembly of the Federation Internationale Pharmaceutique and the 28th International Congress of Pharmaceutical Sciences September 1-7 in Hamburg, Germany. The General Assembly was opened with welcome addresses by German PharmaceuticaJ Association President Enno Ries, FIP President J.H.M. Winters, Lord Mayor of Hamburg Wilhelm Drexelius, Rector of the University of Ham'b urg Werner Ehrlicher and Permanent Undersecretary of State of the Federal Ministry of Health Ludwig von Manger-Koenig. Dr. Heinrich Luebke, President of the Federal Republic of Germany, honored pharmacists with his presence at the opening session. Also during the session, President Winters presented the Host-Madsen Medal to Professor R. Ruyssen, director of the pharmaceutical institute of the University of Ghent, Belgium. The inaugural address was given by Professor Gerhard Martius, la professor at the Free University of Berlin and head of the gynecological department of the Martin Luther Hospital. In his speech, "Birth Control-A World Problem," he called on pharmacists and physicians "to devote themselves to this grave problem which is threatening the very existence of mankind." Other meetings during the conference included sessions on natural and synthetic indole derivatives, medicinal plants with active antimitotic principles, the distribution of medicaments and security in the hospital, individual pouch of medicaments and dressings for servicemen, a list of medicaments indispensable in the case of a catastrophe, the codification of methods of extraction of 'active principles from medicinal plants and the future of pharmacopoeias. The General Assembly held a symposium on the study of FIP structure and made public the results of a questionnaire circulated by an ad hoc commission (see July JAPhA, pages 374-376). Commenting on the report, APhA President Max Eggleston said-
M
Ever since 1962, when we published an editorial in the Journal of the American Pharmaceutical Association, we have been working toward the goal of making FIP a truly worldwide organization in all respects. In 1962 we wrote -"FIP must work to increase membership from continents other than Europe, to secure more officers of the sections, commissions and the bureau from outside Europe and to schedule assemblies in North and South America, Asia and Africa." We are pleased that FIP appointed a commission last year to examine some of the very problems which we brought forth six years ago. Dr. William S.Apple, executive director of the American Pharmaceutical Association, has been received warmly as a member of the council and our recommendations which he has presented from time to time have been given due consideration. One of our initial goals of holding meetings outside Europe was realized last year when your council met with our neighbors to the north during the Canadian Pharmaceutical Association meeting and we are pleased that the council has now agreed to recommend to this assembly that our invitation to hold the 1971 FIP International Congress of Pharmaceutical Sciences in the U.S.A. be accepted. 622
Journal of the AMERICAN PHARMACEUTICAL ASSOCIATION
[The General Assembly subsequently formally accepted the APhA invitation] One point in the commission report which has been of some concern to us is the answer to the question as to whether FIP considers itself a European organiz~tion or a worldwide organization. Without arguing the point as to what FIP previously or presently represents, it is important for us to learn from President Winters that FIP in the future will devote more and more attention to its role as an international organization since there has been created a European organization representing the pharmacists of the Common Market. Eventually this organization, we understand, will serve that as the European Continental organization, leaving FIP free to devote its full attention to its responsibilities as a worldwide society of pharmacy.
Concerning a separate section for community pharmacists, Mark Laventurier, past chairman of the APhA international relations committee, ,s aidGeneral practitioners need a section of their own to pursue their own interests and to be able to speak, to vote and to decide their own policies. I feel that we have the necessary strength as well as the specialists to run our affairs democratically. The criticism that FIP is not an organization meant for the general pharmacist must be dispelled, if FIP is to survive. I am sure that if we had our section now, we would hold a seminar on the subjects of the most serious problems facing our professional lives in our respective countries and all of us would go home 20 times richer in wisdom gathered from our common experience. Given a chance, the community practitioner will act with dignity, wisdom and justice for the benefit of all. The strength of FIP is its diversity of nationality and background. The strength of a democracy resides in the premise that it considers the wish of the many rather than the few. We admit that a section of general practice will be difficult to govern but anything worth achieving usually is difficult. We would not want it any other way. -
ASHP Executive Secretary Joseph Oddis pointed out thatOne point which I feel has not been emphasized in the report o.f the commission involves that of broader representation of officers and program participants. I recognize that the FIP bureau and council wish to leave as much autonomy as possible to the sections, not wishing to dictate whom they shall select as their officers, but it seems in order for me to mention to this General Assembly that each section should consider the advantages of electing officers from countries outside of Europe and the U.S.A. which until now has provided every officer since the inception of the various sections. Furthermore, it is important that program pa.rticipants come from as many different countries as possible. Certainly there must be more pharmacists available from Latin America, Asia and Africa who have contributions to make to this General Assembly than are represented on your present program. I therefore appea.l to a broader representation in all sections since the world is ever decreasing in size because of technological advancements in travel and communications.
Don 'Phillips, current chairman of the APhA international relations committee, statedOne of the questions which the council will be asked to answer is should the administrative powers of the bureau ,now be concentrated in the council, leaving the bureau
Entrance sign at the University of Hamburg auditorium for the 22nd General Assembly of FIP (left) and postage stamp issued by Korea (right) to honor the 2nd Asian Congress of Pharmaceuticals.
Taking time out from the FIP sessions were (left to right) Marc Laventurier, immediate past chairman of the APhA committee on international relations; Don Phillips, current chairman of the international relations committee; J.H.M. Winters, president of FIP and the newly announced recipient of an APhA honorary membership at the 1969 APhA annual meeting in Montreal, and APhA President Max W. Eggleston.
Two honorary presidents of FIP-E. Host-Madsen of Denmark (far left) and Sir Hugh Linstead of Great Britain (far right) flank current FIP President J.H.M. Winters and FIP Secretary-General J.F. Kok, both of The Netherlands, as Dr. Winters presides at the General Assembly of FIP in Hamburg.
William S. Apple, executive director of the American Pharmaceutical Association, represented the U.S.A. in the FIP Council meetings in Hamburg, Germany. More than 40 countries are represented on the CounCil.
Vol. NS8, No. 12, December 1968
623
essentially an advisory body only? , Our ~n~wer, is a resounding yes. Furthermore, we believe this In view of the new direction which FIP seems to be taking-that of a worldwide organization rather than a European organization. It seems to us that to best serve the officers and the council of FIP in an advisory capacity, the bureau should be selected from and by the council. We agree with and commend the commission report when it states-"We would prefer to see the present limitations on the composition of the bureau removed s.o that the field of choice is as wide as possible." We assume that the report is referring to countries of origin for members on the bu· reau, even though members of the bureau are chosen as individuals and not as representatives of their country. This is all the more reason why the bureau should be a type ,o f executive committee of the council since they really represent the council and FIP, not their respective countries.
Following ·the FIP general assembly, the council voted in favor of establishing a section on general praotice of phannacy by a margin of 20 for and 12 against. The council also agreed that a steering committee for the general practice section be compos·e d of one delegate from each country named by their respective national societies. While some felt that a steering committee of 40 to 50 'm·embers would never be capable of accomplishing any effective work, Dr. Apple of the U.S.A. voiced the opinion that nothing prevented the steering committee from electing a small working group from its membership. Dr. Apple also added that CEPO and TPO should start to work on a constitution for the new section since these commissions already represent the nucleus of a steering committee which in the future would be enlarged to include all countries affiliated with FIP. T:his also was the opinion of Sir Hugh Linstead, who added that tif the comlmissions were to be dissolved, their members would undoubtedly become the appointed delegates of the associations to the new section on general practice. Dr. Winters invited George Griffenhagen to report to the council on the discussion about the future relationship between FIP and the Pan-American and Asian Federations. Griffenhagen responded by describing a meeting between the presidents of the three federations as a most useful exchange and stated that agreement had been reached that it would be desirable for ·the Pan-American and Asian Federations to have a seat on the FIP Council as full members. C~mmentin~ on t?is meeting at the General Assembly, SantIago eelSI, preSIdent of the Pan-American Federation of Pharmacy and Biochemistry, statedThe best possible solution is to broaden the action and membership of FIP because it is almost exclusively European and eventually will have to become a worldwide assembly.
. Paulino M. Taningco, president of the Asian FederatIon of Pharmaceutical Associations, saidThere is no d,oubt in ,my mind that FIP will eventually become a truly international organization which will embrace all members of t~e profession of the globe. It may be e~pected therefor~ and , we do hope that you will pursue ~Igorously the action you have studied and the inclusion I~ FIP of FAPA may soon be realized. Given the opportunity, you m~y ~e.st assured that FAPA will do what it can and playa significant role in the FIP objectives.
At the council meeting, Dr. Kohlberg of Israel and Dean Huston of Canada were opposed to the admission of deleg~tes who were not representatives of independent co un!;tIes ~s full m~bers of the council. They stated that contmental bodIes were not ordinary members of FIP and they co~ld therefore only be accepted as guests or as observers. Sir Hugh Linstead concluded that any new con624
Journal of the AMERICAN PHARMACEUTICAL ASSOCIATION
Marc Laventurier, immediate past chairman of the APhA international relations committee, spoke before the General Assembly concerning a separate section for community pharmacists.
stitution should be broad enough to give the council power to elect other members without further specification. With regards it o the FIP Bureau, Sir Hugh explained that there is a certain amount of overlapping activities between the bureau and the council. A number of council members felt that a small "executive committee" consisting of the president, a vice president, secretary and treasurer might replace the bureau, but Dr. Winters felt that "the presidency of FIP would be an impossible task if the president is not assisted by a number of advisers. Dr. KI[e of Germany expressed the view that the council should elect vice presidents-in reality now being appointed by the bureau-and called for "a system which provided the council with the opportunity of making its choice." The council subsequently agreed that the bureau be maintained as a body with usuch limited powers as would enable it to fulfill its function." The Comm.ission on the Future Activities of FIP was then instructed to review the discussions held at Hamburg, prepa~e a report describing the changes that should be made in the FIP statutes and submit the repor.t in 1969 to enable the council to fOmlulate propositions to be put before the General Assembly in 1970. In his closing address President Winters stated· .. Does FIP want to remain a purely European organiza· tion or to widen its activities? ... In the future, FIP will not limit its activities to Europe, but will try to combine in one organization all countries, wherever they may be. · .. The duty of our organization will be to realize the main object of pharmacy which is the same everywhere even if the ways of carrying it out are different. Its basic principle is to help the sick. . .. And if we look back on thjs week we can immediately see that the differences of opinion on the duties and , structure of our organization were less than would have previously been supposed. The discussions on the important report of Sir Hugh Lin, stead and his commission clearly show that our views are similar, even if there are slight differences of opinion over the way in which the changes should be made. Our sec· tions and commissions have shown by their symposia and discussions, their strong support of the structure of FIP. · .. The affiliated associations which together make up our federation, are all in favor of a rapid development of the federation. . .. The only thing I ask of you is to have a little patience and show a little understanding of the problems to be surmounted, and also to understand that our finances are very limited and will determine to a cer· tain extent how much we can achieve. But it is true that "to want to is to be abler"
. Ahighlig~t. of the conference was the adoption of reVIsed advertIsmg standards. The revision resulted from a suggestion made at the ·G eneral Assembly in 1964 by ]APhA Editor GeoItge B. Griffenhagen. The revised code states(a) Advertisements should only be a.ccepted where the
approach style and layout are suitable for announcements directed to members of the pharmaceutical profession. (b) Advertisements should not contain exaggerated, misleading or unjustified claims. (c) There should be a clear distinction between advertisements and editorial matter. (d) Advertisements should not contain disparaging references to other suppliers or products. (e) Advertisements for specialties should state their active constituents using common or nonproprietary names, e.g. international nonproprietary names (WHO) or their equivalent or the corresponding national name. (f) Where precautions are necessary in respect of known harmful side-effects, they should be stated and references to the literature provided, except that this need not apply to "follow-up," "repeat" or "reminder" advertisements of established products for which therapeutic claims are restricted to a general statement as to the class of medication. (g) Adequate evidence must be made available to support a claim for a new drug that it has no side-effects or toxic hazards. (h) Where the supply of a product is restricted by legislation, as much guidance as possible should be given in the advertisement. (i) No advertisements should imply that the pharmacist is unable to assess the relative merits of a product. (j) Advertisements should not be accepted for medical products which are offered to members of .the public through channels other than pharmacies. [The industrial pharmacists' section pointed out that because customs vary, not all countries may be prepared to observe this condition.] . (k) Advertisements should not be accepted which suggest the sale in pharmacies of products or servi.ces which are alien to the profession of pharmacy in any specific country. (I) Advertisements for medicines which excessively emphasize the profit motive or which contain references to competitions or gifts to the public should not be accepted. (m) No advertisement should suggest untruthfully that unless a medicinal product is taken or used, illness may result. (n) Advertisements for homeopathic products should make it clear that the products are based on the homeopathic philosophy.
Sixty-five participants from 19 countries attended the military section meeting. U.S. representatives included Lt: Col. A. Gordon Moore, Army; Cmdr. Robert L. Smith and Lt. Daniel J. Horan, both from the Navy, and Captains Fred E. Coleman and Bruno R. Mazzotta, Air Force. Nine technical papers were presented including. present day studies on stability of medicaments important in war time, civil protection and supply of pharm'a ceutical materials to combat units. Participants also toured a local German Army hospital. APhA',s Griffenhagen and ASHP's George Provost jointly presented a paper ori the "Application of Computer Drug Coding Systems to Pharmacy" at the FIP press and documentation section meeting. .. "Drug coding can playa key role in a total information processing system," according to the presentation. "Pharmacists and other health professionals must assume the leadership in this area, for only by judicious application of automated technics can we hope to keep up with the ever-increasing demands for health services in the years ahead," the report concluded. "Automation is the only .answer to the demand for the increased health services," the authors said. Before attending the Hamburg conference, many attendees participated in the APhA European Tour and Study Mission which left Kennedy Airport in New York City August 10. The group stopped in Stockholm where it toured a modern pharmacy and a large municipal hospital and in Copenhagen where it visited the new Medicinsk Historiske Museum which displays historical phar-
maceutical items. The tour included visits to historical points of interest, local pharmacies and pharmaceutical groups in Berlin; Dubrovnik, Belgrade, Lokrum and Milini, all in Yugoslavia. Future ,meetings of FIP include the 29th International Congress of Pharmaceutical , Sciences in Londori, England September 8-12; 1969; the meeting of the council in Bucharest, Hungary, in September 1969; the 23rd General Assembly of FIP in Geneva, Switzerland, August 31September 5, 1970 and the 31st International Congress of Pharmaceutical Sciences in Washington, D.C., September 5-10, 1971. , Following the FIP meetlng, Don Phillips and Alexander Bell, a Washington, D.C., cOIntnunity pharmacist, continued to tour around the world to attend the F AP A conference in Seoul, Korea, where they were joined by Iowa University college of pharmacy Professor John Lach, his wife and Gary Redman, a U.S. Army pharmaciSt. Some of the highlights of the F AP A Congress were• a report on "Sol,id-Solid I nteractions" by Lach • "The Diplomat in Pharmacy Program" presentation by Jose P.B. Gallardo of the University of Iowa college of pharmacy and a founder of FAPA • retail pharmacy section changed its name to community pharmacy section • Indonesia became a member • whole?aling section changed 'its name to drug distribution section • FIP President Winters elected a permanent member • Don Phillips'-representing the U.S. at the community pharr)1acy section-report on. current pharmaceutical activities in the U.S.A.
The hospital pharmacy section discussed improvement in o~eration and administration of hospital pharmacy, fOCUSIng on preparations in hospitals, attitudes of hospital pharmacists, modern equipment and the training problem for senior coUege of pharmacy students who plan on becoming hospital pharmacists. ~he industrial pharmacy section explored the ways to achIeve an advanced level of industrial pharm,acy. Age?da. includ~d topics on the role of the industrial pharmaCIst m publIc health field, how to adjust foreign and domestic capitals in the .pharmaceutical industry ,a nd how to manage and develop the local resources of drugs. The section also discussed the establishment of an Asian ~or~ulary and a natural . resources development research IIlJstItute. It plans future meetings on these subjects. The pharmaceutical 'e ducation section, where the U.S. was represented by Alexander Bell, discussed extending the ?umber of years in school required to become a pharmaCIst and a pharmacist internship system. . The pharmaceutical jurisprudence section agreed to mtro?uce ~ Pan ~siatic Drug Law covering adulteration, labehng, mIsbrandmg and m,anufacturing. •
Joseph A. Oddis, executive secretary ot ASHP, addressing the General Assembly. His remarks concerned broader representation of officers and program participants in FIP.
Vol. NS8, No. 12, December 1968
625
M
Ever since 1962, when we published an editorial in the Journal of the American Pharmaceutical Association, we have been working toward the goal of making FIP a truly worldwide organization in all respects. In 1962 we wrote -"FIP must work to increase membership from continents other than Europe, to secure more officers of the sections, commissions and the bureau from outside Europe and to schedule assemblies in North and South America, Asia and Africa." We are pleased that FIP appointed a commission last year to examine some of the very problems which we brought forth six years ago. Dr. William S.Apple, executive director of the American Pharmaceutical Association, has been received warmly as a member of the council and our recommendations which he has presented from time to time have been given due consideration. One of our initial goals of holding meetings outside Europe was realized last year when your council met with our neighbors to the north during the Canadian Pharmaceutical Association meeting and we are pleased that the council has now agreed to recommend to this assembly that our invitation to hold the 1971 FIP International Congress of Pharmaceutical Sciences in the U.S.A. be accepted. 622
Journal of the AMERICAN PHARMACEUTICAL ASSOCIATION
[The General Assembly subsequently formally accepted the APhA invitation] One point in the commission report which has been of some concern to us is the answer to the question as to whether FIP considers itself a European organiz~tion or a worldwide organization. Without arguing the point as to what FIP previously or presently represents, it is important for us to learn from President Winters that FIP in the future will devote more and more attention to its role as an international organization since there has been created a European organization representing the pharmacists of the Common Market. Eventually this organization, we understand, will serve that as the European Continental organization, leaving FIP free to devote its full attention to its responsibilities as a worldwide society of pharmacy.
Concerning a separate section for community pharmacists, Mark Laventurier, past chairman of the APhA international relations committee, ,s aidGeneral practitioners need a section of their own to pursue their own interests and to be able to speak, to vote and to decide their own policies. I feel that we have the necessary strength as well as the specialists to run our affairs democratically. The criticism that FIP is not an organization meant for the general pharmacist must be dispelled, if FIP is to survive. I am sure that if we had our section now, we would hold a seminar on the subjects of the most serious problems facing our professional lives in our respective countries and all of us would go home 20 times richer in wisdom gathered from our common experience. Given a chance, the community practitioner will act with dignity, wisdom and justice for the benefit of all. The strength of FIP is its diversity of nationality and background. The strength of a democracy resides in the premise that it considers the wish of the many rather than the few. We admit that a section of general practice will be difficult to govern but anything worth achieving usually is difficult. We would not want it any other way. -
ASHP Executive Secretary Joseph Oddis pointed out thatOne point which I feel has not been emphasized in the report o.f the commission involves that of broader representation of officers and program participants. I recognize that the FIP bureau and council wish to leave as much autonomy as possible to the sections, not wishing to dictate whom they shall select as their officers, but it seems in order for me to mention to this General Assembly that each section should consider the advantages of electing officers from countries outside of Europe and the U.S.A. which until now has provided every officer since the inception of the various sections. Furthermore, it is important that program pa.rticipants come from as many different countries as possible. Certainly there must be more pharmacists available from Latin America, Asia and Africa who have contributions to make to this General Assembly than are represented on your present program. I therefore appea.l to a broader representation in all sections since the world is ever decreasing in size because of technological advancements in travel and communications.
Don 'Phillips, current chairman of the APhA international relations committee, statedOne of the questions which the council will be asked to answer is should the administrative powers of the bureau ,now be concentrated in the council, leaving the bureau
Entrance sign at the University of Hamburg auditorium for the 22nd General Assembly of FIP (left) and postage stamp issued by Korea (right) to honor the 2nd Asian Congress of Pharmaceuticals.
Taking time out from the FIP sessions were (left to right) Marc Laventurier, immediate past chairman of the APhA committee on international relations; Don Phillips, current chairman of the international relations committee; J.H.M. Winters, president of FIP and the newly announced recipient of an APhA honorary membership at the 1969 APhA annual meeting in Montreal, and APhA President Max W. Eggleston.
Two honorary presidents of FIP-E. Host-Madsen of Denmark (far left) and Sir Hugh Linstead of Great Britain (far right) flank current FIP President J.H.M. Winters and FIP Secretary-General J.F. Kok, both of The Netherlands, as Dr. Winters presides at the General Assembly of FIP in Hamburg.
William S. Apple, executive director of the American Pharmaceutical Association, represented the U.S.A. in the FIP Council meetings in Hamburg, Germany. More than 40 countries are represented on the CounCil.
Vol. NS8, No. 12, December 1968
623
essentially an advisory body only? , Our ~n~wer, is a resounding yes. Furthermore, we believe this In view of the new direction which FIP seems to be taking-that of a worldwide organization rather than a European organization. It seems to us that to best serve the officers and the council of FIP in an advisory capacity, the bureau should be selected from and by the council. We agree with and commend the commission report when it states-"We would prefer to see the present limitations on the composition of the bureau removed s.o that the field of choice is as wide as possible." We assume that the report is referring to countries of origin for members on the bu· reau, even though members of the bureau are chosen as individuals and not as representatives of their country. This is all the more reason why the bureau should be a type ,o f executive committee of the council since they really represent the council and FIP, not their respective countries.
Following ·the FIP general assembly, the council voted in favor of establishing a section on general praotice of phannacy by a margin of 20 for and 12 against. The council also agreed that a steering committee for the general practice section be compos·e d of one delegate from each country named by their respective national societies. While some felt that a steering committee of 40 to 50 'm·embers would never be capable of accomplishing any effective work, Dr. Apple of the U.S.A. voiced the opinion that nothing prevented the steering committee from electing a small working group from its membership. Dr. Apple also added that CEPO and TPO should start to work on a constitution for the new section since these commissions already represent the nucleus of a steering committee which in the future would be enlarged to include all countries affiliated with FIP. T:his also was the opinion of Sir Hugh Linstead, who added that tif the comlmissions were to be dissolved, their members would undoubtedly become the appointed delegates of the associations to the new section on general practice. Dr. Winters invited George Griffenhagen to report to the council on the discussion about the future relationship between FIP and the Pan-American and Asian Federations. Griffenhagen responded by describing a meeting between the presidents of the three federations as a most useful exchange and stated that agreement had been reached that it would be desirable for ·the Pan-American and Asian Federations to have a seat on the FIP Council as full members. C~mmentin~ on t?is meeting at the General Assembly, SantIago eelSI, preSIdent of the Pan-American Federation of Pharmacy and Biochemistry, statedThe best possible solution is to broaden the action and membership of FIP because it is almost exclusively European and eventually will have to become a worldwide assembly.
. Paulino M. Taningco, president of the Asian FederatIon of Pharmaceutical Associations, saidThere is no d,oubt in ,my mind that FIP will eventually become a truly international organization which will embrace all members of t~e profession of the globe. It may be e~pected therefor~ and , we do hope that you will pursue ~Igorously the action you have studied and the inclusion I~ FIP of FAPA may soon be realized. Given the opportunity, you m~y ~e.st assured that FAPA will do what it can and playa significant role in the FIP objectives.
At the council meeting, Dr. Kohlberg of Israel and Dean Huston of Canada were opposed to the admission of deleg~tes who were not representatives of independent co un!;tIes ~s full m~bers of the council. They stated that contmental bodIes were not ordinary members of FIP and they co~ld therefore only be accepted as guests or as observers. Sir Hugh Linstead concluded that any new con624
Journal of the AMERICAN PHARMACEUTICAL ASSOCIATION
Marc Laventurier, immediate past chairman of the APhA international relations committee, spoke before the General Assembly concerning a separate section for community pharmacists.
stitution should be broad enough to give the council power to elect other members without further specification. With regards it o the FIP Bureau, Sir Hugh explained that there is a certain amount of overlapping activities between the bureau and the council. A number of council members felt that a small "executive committee" consisting of the president, a vice president, secretary and treasurer might replace the bureau, but Dr. Winters felt that "the presidency of FIP would be an impossible task if the president is not assisted by a number of advisers. Dr. KI[e of Germany expressed the view that the council should elect vice presidents-in reality now being appointed by the bureau-and called for "a system which provided the council with the opportunity of making its choice." The council subsequently agreed that the bureau be maintained as a body with usuch limited powers as would enable it to fulfill its function." The Comm.ission on the Future Activities of FIP was then instructed to review the discussions held at Hamburg, prepa~e a report describing the changes that should be made in the FIP statutes and submit the repor.t in 1969 to enable the council to fOmlulate propositions to be put before the General Assembly in 1970. In his closing address President Winters stated· .. Does FIP want to remain a purely European organiza· tion or to widen its activities? ... In the future, FIP will not limit its activities to Europe, but will try to combine in one organization all countries, wherever they may be. · .. The duty of our organization will be to realize the main object of pharmacy which is the same everywhere even if the ways of carrying it out are different. Its basic principle is to help the sick. . .. And if we look back on thjs week we can immediately see that the differences of opinion on the duties and , structure of our organization were less than would have previously been supposed. The discussions on the important report of Sir Hugh Lin, stead and his commission clearly show that our views are similar, even if there are slight differences of opinion over the way in which the changes should be made. Our sec· tions and commissions have shown by their symposia and discussions, their strong support of the structure of FIP. · .. The affiliated associations which together make up our federation, are all in favor of a rapid development of the federation. . .. The only thing I ask of you is to have a little patience and show a little understanding of the problems to be surmounted, and also to understand that our finances are very limited and will determine to a cer· tain extent how much we can achieve. But it is true that "to want to is to be abler"
. Ahighlig~t. of the conference was the adoption of reVIsed advertIsmg standards. The revision resulted from a suggestion made at the ·G eneral Assembly in 1964 by ]APhA Editor GeoItge B. Griffenhagen. The revised code states(a) Advertisements should only be a.ccepted where the
approach style and layout are suitable for announcements directed to members of the pharmaceutical profession. (b) Advertisements should not contain exaggerated, misleading or unjustified claims. (c) There should be a clear distinction between advertisements and editorial matter. (d) Advertisements should not contain disparaging references to other suppliers or products. (e) Advertisements for specialties should state their active constituents using common or nonproprietary names, e.g. international nonproprietary names (WHO) or their equivalent or the corresponding national name. (f) Where precautions are necessary in respect of known harmful side-effects, they should be stated and references to the literature provided, except that this need not apply to "follow-up," "repeat" or "reminder" advertisements of established products for which therapeutic claims are restricted to a general statement as to the class of medication. (g) Adequate evidence must be made available to support a claim for a new drug that it has no side-effects or toxic hazards. (h) Where the supply of a product is restricted by legislation, as much guidance as possible should be given in the advertisement. (i) No advertisements should imply that the pharmacist is unable to assess the relative merits of a product. (j) Advertisements should not be accepted for medical products which are offered to members of .the public through channels other than pharmacies. [The industrial pharmacists' section pointed out that because customs vary, not all countries may be prepared to observe this condition.] . (k) Advertisements should not be accepted which suggest the sale in pharmacies of products or servi.ces which are alien to the profession of pharmacy in any specific country. (I) Advertisements for medicines which excessively emphasize the profit motive or which contain references to competitions or gifts to the public should not be accepted. (m) No advertisement should suggest untruthfully that unless a medicinal product is taken or used, illness may result. (n) Advertisements for homeopathic products should make it clear that the products are based on the homeopathic philosophy.
Sixty-five participants from 19 countries attended the military section meeting. U.S. representatives included Lt: Col. A. Gordon Moore, Army; Cmdr. Robert L. Smith and Lt. Daniel J. Horan, both from the Navy, and Captains Fred E. Coleman and Bruno R. Mazzotta, Air Force. Nine technical papers were presented including. present day studies on stability of medicaments important in war time, civil protection and supply of pharm'a ceutical materials to combat units. Participants also toured a local German Army hospital. APhA',s Griffenhagen and ASHP's George Provost jointly presented a paper ori the "Application of Computer Drug Coding Systems to Pharmacy" at the FIP press and documentation section meeting. .. "Drug coding can playa key role in a total information processing system," according to the presentation. "Pharmacists and other health professionals must assume the leadership in this area, for only by judicious application of automated technics can we hope to keep up with the ever-increasing demands for health services in the years ahead," the report concluded. "Automation is the only .answer to the demand for the increased health services," the authors said. Before attending the Hamburg conference, many attendees participated in the APhA European Tour and Study Mission which left Kennedy Airport in New York City August 10. The group stopped in Stockholm where it toured a modern pharmacy and a large municipal hospital and in Copenhagen where it visited the new Medicinsk Historiske Museum which displays historical phar-
maceutical items. The tour included visits to historical points of interest, local pharmacies and pharmaceutical groups in Berlin; Dubrovnik, Belgrade, Lokrum and Milini, all in Yugoslavia. Future ,meetings of FIP include the 29th International Congress of Pharmaceutical , Sciences in Londori, England September 8-12; 1969; the meeting of the council in Bucharest, Hungary, in September 1969; the 23rd General Assembly of FIP in Geneva, Switzerland, August 31September 5, 1970 and the 31st International Congress of Pharmaceutical Sciences in Washington, D.C., September 5-10, 1971. , Following the FIP meetlng, Don Phillips and Alexander Bell, a Washington, D.C., cOIntnunity pharmacist, continued to tour around the world to attend the F AP A conference in Seoul, Korea, where they were joined by Iowa University college of pharmacy Professor John Lach, his wife and Gary Redman, a U.S. Army pharmaciSt. Some of the highlights of the F AP A Congress were• a report on "Sol,id-Solid I nteractions" by Lach • "The Diplomat in Pharmacy Program" presentation by Jose P.B. Gallardo of the University of Iowa college of pharmacy and a founder of FAPA • retail pharmacy section changed its name to community pharmacy section • Indonesia became a member • whole?aling section changed 'its name to drug distribution section • FIP President Winters elected a permanent member • Don Phillips'-representing the U.S. at the community pharr)1acy section-report on. current pharmaceutical activities in the U.S.A.
The hospital pharmacy section discussed improvement in o~eration and administration of hospital pharmacy, fOCUSIng on preparations in hospitals, attitudes of hospital pharmacists, modern equipment and the training problem for senior coUege of pharmacy students who plan on becoming hospital pharmacists. ~he industrial pharmacy section explored the ways to achIeve an advanced level of industrial pharm,acy. Age?da. includ~d topics on the role of the industrial pharmaCIst m publIc health field, how to adjust foreign and domestic capitals in the .pharmaceutical industry ,a nd how to manage and develop the local resources of drugs. The section also discussed the establishment of an Asian ~or~ulary and a natural . resources development research IIlJstItute. It plans future meetings on these subjects. The pharmaceutical 'e ducation section, where the U.S. was represented by Alexander Bell, discussed extending the ?umber of years in school required to become a pharmaCIst and a pharmacist internship system. . The pharmaceutical jurisprudence section agreed to mtro?uce ~ Pan ~siatic Drug Law covering adulteration, labehng, mIsbrandmg and m,anufacturing. •
Joseph A. Oddis, executive secretary ot ASHP, addressing the General Assembly. His remarks concerned broader representation of officers and program participants in FIP.
Vol. NS8, No. 12, December 1968
625